217 related articles for article (PubMed ID: 26393431)
1. MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function.
Maiti P; Gregg LC; McDonald MP
Behav Brain Res; 2016 Feb; 298(Pt B):192-201. PubMed ID: 26393431
[TBL] [Abstract][Full Text] [Related]
2. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
[TBL] [Abstract][Full Text] [Related]
3. Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Pflibsen L; Stang KA; Sconce MD; Wilson VB; Hood RL; Meshul CK; Mitchell SH
J Neurosci Res; 2015 Dec; 93(12):1849-64. PubMed ID: 26332770
[TBL] [Abstract][Full Text] [Related]
4. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
5. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice.
Hong Z; Wang G; Gu J; Pan J; Bai L; Zhang S; Chen SD
Eur J Neurosci; 2007 Sep; 26(6):1500-8. PubMed ID: 17714494
[TBL] [Abstract][Full Text] [Related]
6. Treadmill exercise modifies dopamine receptor expression in the prefrontal cortex of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of Parkinson's disease.
Kintz N; Petzinger GM; Jakowec MW
Neuroreport; 2017 Oct; 28(15):987-995. PubMed ID: 28877102
[TBL] [Abstract][Full Text] [Related]
7. Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease.
Adeosun SO; Hou X; Jiao Y; Zheng B; Henry S; Hill R; He Z; Pani A; Kyle P; Ou X; Mosley T; Farley JM; Stockmeier C; Paul I; Bigler S; Brinton RD; Smeyne R; Wang JM
PLoS One; 2012; 7(11):e50040. PubMed ID: 23209637
[TBL] [Abstract][Full Text] [Related]
8. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
Hofele K; Sedelis M; Auburger GW; Morgan S; Huston JP; Schwarting RK
Exp Neurol; 2001 Mar; 168(1):116-22. PubMed ID: 11170726
[TBL] [Abstract][Full Text] [Related]
10. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
Lin Z; Dodd CA; Filipov NM
Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of Danshensu in Parkinson's disease mouse model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Han B; Che X; Zhao Y; Li C; He J; Lu Y; Wang Z; Wang T
Behav Pharmacol; 2019 Feb; 30(1):36-44. PubMed ID: 29847337
[TBL] [Abstract][Full Text] [Related]
12. Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice.
Mu X; He GR; Yuan X; Li XX; Du GH
Pharmacol Biochem Behav; 2011 Apr; 98(2):286-91. PubMed ID: 21262257
[TBL] [Abstract][Full Text] [Related]
13. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
Choi DY; Lee MK; Hong JT
Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
[TBL] [Abstract][Full Text] [Related]
14. Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.
Vucković MG; Wood RI; Holschneider DP; Abernathy A; Togasaki DM; Smith A; Petzinger GM; Jakowec MW
Neurobiol Dis; 2008 Nov; 32(2):319-27. PubMed ID: 18718537
[TBL] [Abstract][Full Text] [Related]
15. Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats.
Capitelli C; Sereniki A; Lima MM; Reksidler AB; Tufik S; Vital MA
Eur J Pharmacol; 2008 Oct; 594(1-3):101-8. PubMed ID: 18674531
[TBL] [Abstract][Full Text] [Related]
16. Properties of 3-methyl-TIQ and 3-methyl-N-propargyl-TIQ for preventing MPTP-induced parkinsonism-like symptoms in mice.
Saitoh K; Abe K; Chiba T; Katagiri N; Saitoh T; Horiguchi Y; Nojima H; Taguchi K
Pharmacol Rep; 2013; 65(5):1204-12. PubMed ID: 24399716
[TBL] [Abstract][Full Text] [Related]
17. Social odor recognition: a novel behavioral model for cognitive dysfunction in Parkinson's disease.
Monaghan MM; Leddy L; Sung ML; Albinson K; Kubek K; Pangalos MN; Reinhart PH; Zaleska MM; Comery TA
Neurodegener Dis; 2010; 7(1-3):153-9. PubMed ID: 20197696
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection in Parkinson models varies with toxin administration protocol.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
[TBL] [Abstract][Full Text] [Related]
19. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.
Minnema DJ; Travis KZ; Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck MJ; Mathews JM; Tisdel MO; Cook AR; Botham PA; Smith LL
Regul Toxicol Pharmacol; 2014 Mar; 68(2):250-8. PubMed ID: 24389362
[TBL] [Abstract][Full Text] [Related]
20. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia.
Fisher BE; Petzinger GM; Nixon K; Hogg E; Bremmer S; Meshul CK; Jakowec MW
J Neurosci Res; 2004 Aug; 77(3):378-90. PubMed ID: 15248294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]